Document is current
Any future updates will be listed below
-
Authors
Nakatsu, Geicho
Andreeva, Natalia
MacDonald, Meghan H.
Garrett, Wendy S. https://orcid.org/0000-0002-5092-0150
- License Information
-
More Information
Article History
Received: 13 February 2023
Accepted: 20 May 2024
First Online: 21 June 2024
Competing interests
: W.S.G. is on the scientific advisory board of Empress Therapeutics, Freya Biosciences, Seres Therapeutics, Scipher Medicine and Sail Biosciences, all unrelated to this review article. W.S.G.’s laboratory receives funding from Merck and Astellas. The other authors declare no competing interests.
